BACKGROUND: Coronaviruses (CoVs) primarily cause enzootic infections in birds and mammals but, in the last few decades, have shown to be capable of infecting humans as well. The outbreak of severe acute respiratory syndrome (SARS) in 2003 and, more recently, Middle-East respiratory syndrome (MERS) has demonstrated the lethality of CoVs when they cross the species…
Virology Journal Template
Write in a clean editor, then format for Virology Journal in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Virology Journal format
Virology Journal is a peer-reviewed journal published by BMC (BioMed Central), covering Animal Virus Infections Studies, Respiratory viral infections research, Virus-based gene therapy research. Over its lifetime it has published 5,651 papers, which have received 163,459 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Virology Journal. 2023;12(3):45–58.
Formats any DOI in Virology Journal style. No sign-up. |
| Publishes research in | Animal Virus Infections Studies Respiratory viral infections research Virus-based gene therapy research Viral Infections and Immunology Research Influenza Virus Research Studies |
| ISSN | 1743-422X |
| Citation impact (2-yr) | 3.84 |
| h-index | 130 |
| i10-index | 3,729 |
| Article processing charge | $2,318 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Chinese Academy of Agricultural Sciences |
| Journal website | www.virologyj.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Virology Journal per year
Citation impact of Virology Journal by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Virology Journal
BACKGROUND: Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available. RESULTS: We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or…
The enteric disease of swine recognized in the early 1970s in Europe was initially described as "epidemic viral diarrhea" and is now termed "porcine epidemic diarrhea (PED)". The coronavirus referred to as PED virus (PEDV) was determined to be the etiologic agent of this disease in the late 1970s. Since then the disease has been…
BACKGROUND: The rate at which COVID-19 has spread throughout the globe has been alarming. While the role of fomite transmission is not yet fully understood, precise data on the environmental stability of SARS-CoV-2 is required to determine the risks of fomite transmission from contaminated surfaces. METHODS: This study measured the survival rates of infectious SARS-CoV-2,…
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This virus affects the respiratory tract and usually leads to pneumonia in most patients and acute respiratory distress syndrome (ARDS) in 15% of cases. ARDS is one of the leading causes of death in…